Composition
- Active ingredients
- PALONOSETRON HYDROCHLORIDE EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- PALONOSETRON HYDROCHLORIDE EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA021372-002 · Discontinued
- PALONOSETRON HYDROCHLORIDE EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA021372-001 · Discontinued
- PALONOSETRON HYDROCHLORIDE EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA022233.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Aloxi
- Active substance
- palonosetron hydrochloride
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Helsinn Hlthcare
- Status
- Discontinued
- FDA approval
- 22 Aug 2008
- Application
- NDA022233-001